Irbesartan Tablet
Product Images NDC 71335-2168

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Irbesartan (NDC 71335-2168). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713352168)

Label for Irbesartan 150 mg tablet, packaged by Bryant Ranch Prepack in Burbank, CA. The label indicates the tablet is white to off-white, oval, and biconvex. It compares to Avapro 150 mg tablet by Zhejiang Huahai Pharma Co., Ltd. The pack contains 30 tablets. Storage instructions specify room temperature 20°-25°C (68°-77°F). Includes a barcode and NDC 71335-2168-1.*

FDA Label Image

Structure (Spl Image1 Structure)

Chemical structure of irbesartan, showing its specific molecular arrangement and bonds as part of its active chemical composition.*

FDA Label Image

Figure 1 (Spl Image2 Figure1)

A scatter plot with a curve showing the placebo-subtracted reduction in trough SeSBP (systolic blood pressure) as a function of Irbesartan dose in mg/day. The x-axis ranges from 0 to 900 mg/day, and the y-axis shows blood pressure changes in mmHg from -4 to 12. Data points and a fitted curve indicate increasing reduction with dose, leveling off at higher doses.*

FDA Label Image

Figure 2 (Spl Image3 Figure2)

A scatter plot with a curve illustrating the placebo-subtracted reduction in trough seated diastolic blood pressure (SeDBP) as a function of Irbesartan dose in mg per day, ranging from 0 to 900 mg/day. The y-axis measures blood pressure reduction in mmHg from -2 to 8.*

FDA Label Image

Figure 3 (Spl Image4 Figure3)

A cumulative event rate line graph comparing Irbesartan, Amlodipine, and Placebo over 57 months of follow-up. The y-axis represents cumulative event rate (%) and the x-axis shows months of follow-up. The graph includes a risk ratio and p-value table comparing Irbesartan versus Placebo and Amlodipine.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.